Lithium and valproate acid protect NSC34 cells from H2O 2-induced oxidative stress and upregulate expressions of SIRT3 and CARM1

Neuroendocrinology Letters

Volumn 34, Issue 7, 2013, Pages 648-654

  Wang, Jing ^a   Feng, Honglin ^a   Zhang, Jun ^a   Jiang, Hongquan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

CARM1; Lithium; Oxidative stress; PGC 1 ; SIRT3; Valproate acid

Indexed keywords

COACTIVATOR ASSOCIATED ARGININE METHYLTRANSFERASE 1; HYDROGEN PEROXIDE; LITHIUM; METHYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SIRTUIN 3; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; VALPROIC ACID;

AEROBIC METABOLISM; ARTICLE; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CYTOTOXICITY; ENZYME ACTIVITY; IC 50; MITOCHONDRIAL RESPIRATION; MOTONEURON; NEUROBLASTOMA CELL; NEUROPROTECTION; OXIDATIVE STRESS; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; ANTIMANIC AGENTS; CELL DEATH; CELL LINE, TUMOR; DRUG INTERACTIONS; HYDROGEN PEROXIDE; INHIBITORY CONCENTRATION 50; LITHIUM COMPOUNDS; MOTOR NEURONS; NEUROPROTECTIVE AGENTS; NF-E2-RELATED FACTOR 2; OXIDANTS; OXIDATIVE STRESS; PROTEIN-ARGININE N-METHYLTRANSFERASES; SIRTUIN 3; UP-REGULATION; VALPROIC ACID;

EID: 84894501924     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Anderson RM, Barger JL, Edwards MG et al. (2008). Dynamic regulation of PGC-1alpha localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response. Aging Cell. 7: 101-111.
2. Andreazza AC, Kauer-Sant'anna M, Frey BN et al. (2008). Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord. 111: 135-144.
3. Barber SC, Shaw PJ (2010). Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med. 48: 629-641.
4. Chen H, Yoshioka H, Kim GS et al. (2011). Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal. 14: 1505-1517.
5. Chiu CT, Wang Z, Hunsberger JG and Chuang DM (2013). Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev. 65: 105-142.
6. Cowell RM, Talati P, Blake KR et al. (2009). Identification of novel targets for PGC-1alpha and histone deacetylase inhibitors in neuroblastoma cells. Biochem Biophys Res Commun. 379: 578-582.
7. Giralt A, Hondares E, Villena JA et al. (2011). Peroxisome proliferator-activated receptor-gamma coactivator-1alpha controls transcription of the Sirt3 gene, an essential component of the thermogenic brown adipocyte phenotype. J Biol Chem. 286: 16958-16966.
8. Hiroi T, Wei H, Hough C et al. (2005). Protracted lithium treatment protects against the ER stress elicited by thapsigargin in rat PC12 cells: roles of intracellular calcium, GRP78 and Bcl-2. Pharmacogenomics J. 5: 102-111. (Pubitemid 40468117)
9. Hsu YY, Chen CS, Wu SN et al. (2012). Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase/Akt-dependent mechanism in NSC34 motor neuron-like cells. Eur J Pharm Sci. 46: 415-425.
10. Klepac N, Relja M, Klepac R et al. (2007). Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects: a cross-sectional study. J Neurol. 254: 1676-1683.
11. Kong X, Wang R, Xue Y et al. (2010). Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One. 5: e11707.
12. Lai JS, Zhao C, Warsh JJ and Li PP (2006). Cytoprotection by lithium and valproate varies between cell types and cellular stresses. Eur J Pharmacol. 539: 18-26. (Pubitemid 43783516)
13. McGill JK, Beal MF (2006). PGC-1alpha, a new therapeutic target in Huntington's disease? Cell. 127: 465-468. (Pubitemid 44647438)
14. Perry G, Cash AD, Smith MA (2002). Alzheimer Disease and Oxidative Stress. J Biomed Biotechnol. 2: 120-123. (Pubitemid 44204507)
15. Rizzardini M, Lupi M, Mangolini A et al. (2006). Neurodegeneration induced by complex I inhibition in a cellular model of familial amyotrophic lateral sclerosis. Brain Res Bull. 69: 465-474. (Pubitemid 43675735)
16. Rona-Voros K, Weydt P (2010). The role of PGC-1alpha in the pathogenesis of neurodegenerative disorders. Curr Drug Targets. 11: 1262-1269.
17. Rouaux C, Jokic N, Mbebi C et al. (2003). Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. Embo J. 22: 6537-6549. (Pubitemid 38009601)
18. Ryu H, Jeon GS, Cashman NR et al. (2011). Differential expression of c-Ret in motor neurons versus non-neuronal cells is linked to the pathogenesis of ALS. Lab Invest. 91: 342-352.
19. Song W, Song Y, Kincaid B et al. (2012) Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1alpha. Neurobiol Dis. 51: 72-81.
20. Struewing IT, Barnett CD, Tang T, Mao CD (2007). Lithium increases PGC-1alpha expression and mitochondrial biogenesis in primary bovine aortic endothelial cells. FEBS J. 274: 2749-2765. (Pubitemid 46800545)
21. Wang SC, Dowhan DH, Eriksson NA, Muscat GE (2012). CARM1/PRMT4 is necessary for the glycogen gene expression programme in skeletal muscle cells. Biochem J. 444: 323-331.
22. Yadav N, Cheng D, Richard S et al. (2008). CARM1 promotes adipocyte differentiation by coactivating PPARgamma. EMBO Rep. 9: 193-198. (Pubitemid 351223458)
23. Zarate CA Jr, Singh J, Manji HK (2006). Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry. 59: 1006-1020. (Pubitemid 43849653)
24. Zhang N, Liu Z, Han Q et al. (2011). Development of one-step SYBR Green real-time RT-PCR for quantifying bovine viral diarrhea virus type-1 and its comparison with conventional RT-PCR. Virol J. 8: 374.